Tarsus Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.26 | $157.41 M | -0.91 | 51 |
![]() ALDX
Aldeyra Therapeutics, Inc. |
$6.91 | $229.34 M | -7.36 | 9 |
![]() CNTA
Centessa Pharmaceuticals plc |
$17.14 | $884.24 M | -11.3 | 75 |
![]() CNTB
Connect Biopharma Holdings Limited |
$0.86 | $108.00 M | -2.19 | 81 |
![]() DSGN
Design Therapeutics, Inc. |
$4.71 | $217.51 M | -5.35 | 54 |
![]() ELDN
Eledon Pharmaceuticals, Inc. |
$3.65 | $107.05 M | 4.97 | 20 |
![]() ETON
Eton Pharmaceuticals, Inc. |
$15.58 | $92.74 M | -73.9 | 30 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.27 | $243.38 M | -3.52 | 133 |
![]() GNFT
Genfit S.A. |
$3.51 | $269.95 M | 8.78 | 169 |
![]() HOWL
Werewolf Therapeutics, Inc. |
$1.20 | $151.66 M | -0.74 | 46 |
![]() IKNA
Ikena Oncology, Inc. |
$1.35 | $84.45 M | -1.32 | 10 |
![]() LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 |
![]() NUVB
Nuvation Bio Inc. |
$2.14 | $684.66 M | -1.01 | 220 |
![]() NUVL
Nuvalent, Inc. |
$77.01 | $5.11 B | -19.6 | 142 |
![]() OPT
Opthea Limited |
$3.18 | $214.34 M | -1.44 | 33 |
![]() PEPG
PepGen Inc. |
$2.40 | $537.15 M | -0.84 | 81 |
![]() PHVS
Pharvaris N.V. |
$16.67 | $843.31 M | -5.99 | 92 |
![]() RLYB
Rallybio Corporation |
$0.63 | $61.34 M | -0.48 | 25 |
![]() STOK
Stoke Therapeutics, Inc. |
$8.60 | $774.50 M | -4.13 | 110 |
![]() TRDA
Entrada Therapeutics, Inc. |
$10.81 | $531.37 M | 6.45 | 183 |
![]() TVTX
Travere Therapeutics, Inc. |
$19.73 | $542.80 M | -4.85 | 385 |
![]() TYRA
Tyra Biosciences, Inc. |
$11.50 | $1.04 B | -7.14 | 49 |